Personalized Medicine in Dermatology: A Rare Subset of T Cells May Predict Which Melanoma Patients Benefit Most From ICIs
A rare subset of T cells known as Vd1-gd T cells can help predict which melanoma patients may benefit most from immunotherapy, according to research in Nature Cancer. Previous research has shown that immune checkpoint inhibitors (ICIs) can ‘reactivate’ T cells formerly suppressed by cancer cells. The T cells can then kill cancer cells by recognizing cancer […]